Key Highlights
- $21.5 million Series B financing round led by Nexus NeuroTech Ventures and Venture Investors Health Fund.
- First-in-kind EarliPoint Evaluation aids in diagnosing autism in children 16-to-30 months old.
- Funds will expand commercialization and advance clinical research.
Source: Business Wire
Notable Quotes
- “EarliTec is pioneering diagnostic and treatment solutions for children with autism, and we’re thrilled to support their innovative efforts,” – Jim Adox, Executive Managing Director at Venture Investors Health Fund
- “This funding round will enable EarliTec to further advance their groundbreaking technology and expand access to their transformative solutions,” – William Marks, M.D., Chief Medical Officer at Nexus NeuroTech Ventures
- “There is a severe unmet need in autism diagnosis, and families often face a challenging path to diagnosis… EarliPoint represents a meaningful step forward in better, accessible care for autistic children,” – Ami Klin, Ph.D., Chief Clinical Officer and Founder at EarliTec
SoHC's Take
The Series B financing of EarliTec Diagnostics is a significant milestone in the quest for better diagnostic and therapeutic solutions for autism, a condition that affects 1 in 36 children. With the EarliPoint Evaluation, EarliTec is at the forefront of addressing a critical gap in the early diagnosis and treatment of autism, promising to transform care for the better. The backing by Nexus NeuroTech Ventures and Venture Investors Health Fund not only validates the potential of EarliTec’s technology but also highlights the growing recognition of the need for innovative approaches in the healthcare sector. The anticipated expansion of commercialization and clinical research efforts is expected to bolster the availability and efficacy of autism diagnostics, underscoring the importance of technology in enhancing patient care. This development is a hopeful sign for families and clinicians alike, signaling a move towards more accessible and effective solutions for the challenges posed by autism.
